Search results

Filter

Filetype

Your search for "*" yielded 563474 hits

Several diabetes researchers at LUDC receive grants from the Swedish Research Council

Six researchers at Lund University Diabetes Centre (LUDC) were recently awarded grants within medicine and health by the Swedish Research Council (Vetenskapsrådet). The six researchers are members of the strategic research area Excellence of diabetes research in Sweden (EXODIAB) at Lund University. Daniel Agardh, adjunct professor in pediatrics and research group leader in celiac disease and diabe

https://www.ludc.lu.se/article/several-diabetes-researchers-ludc-receive-grants-swedish-research-council - 2026-08-21

Learning more about the endocrine system could lead to fewer cases of type 2 diabetes and obesity

How much water do we need to drink to stay healthy? How do different diets affect our metabolism? Studies of various hormones in the body are providing diabetes researchers with new answers to these questions. The goal is to develop individualized treatments and dietary recommendations that could lower the risk of developing obesity and diseases such as type 2 diabetes. The endocrine system and th

https://www.ludc.lu.se/article/learning-more-about-endocrine-system-could-lead-fewer-cases-type-2-diabetes-and-obesity - 2026-08-21

World Diabetes Day in Malmö 2015

This article is over 5 years old, and the information may therefore be outdated. World Diabetes Day in Malmö was all about science. Researchers told the latest on diabetes research from stem cells to diet and the smallest hade the opportunity to becoming scientists - and learn what makes a strawberry a strawberry .  Organisers:Lund University Diabetes Centre, Scania Hospital, Diabetes Society in M

https://www.ludc.lu.se/article/world-diabetes-day-malmo-2015 - 2026-08-21

ERC grant for research on diabetes

Professor Charlotte Ling at Lund University Diabetes Centre (LUDC) has been awarded a Proof of Concept Grant by the European Research Council, ERC, for the further development of her successful research on epigenetic biomarkers. The innovation-driven research project will investigate biomarkers for predicting who benefits from metformin in the treatment of type 2 diabetes. In her research, Charlot

https://www.ludc.lu.se/article/erc-grant-research-diabetes - 2026-08-21

Diabetes researcher Tove Fall is the recipient of the Leif C. Groop award 2023

Tove Fall became a familiar face during the Covid-19 pandemic when she was often seen in Swedish media talking about the spread and progression of the disease in Sweden. She is also an outstanding diabetes researcher who uses large quantities of data to gain a better understanding of the development of diabetes. Tove Fall is now awarded the Leif C. Groop award for outstanding diabetes research for

https://www.ludc.lu.se/article/diabetes-researcher-tove-fall-recipient-leif-c-groop-award-2023 - 2026-08-21

PAX5 – a gene strongly associated with impaired insulin secretion in type 2 diabetes

Researchers have identified 395 genes that are differently expressed in people with type 2 diabetes. One of the genes proved to be very strongly associated with impaired insulin secretion. Now, researchers want to investigate if it is possible to use the genetic CRISPR/Cas9 scissors to correct the gene’s activity. The research team’s scientific paper was published in the Journal of Clinical Invest

https://www.ludc.lu.se/article/pax5-gene-strongly-associated-impaired-insulin-secretion-type-2-diabetes - 2026-08-21

A genetic-driven approach defining two obesity profiles that convey highly concordant and discordant diabetogenic effects

A team of researchers led by Daniel E. Coral and Paul W. Franks at LUDC have used human genetics to do a phenome-wide analysis of the degree of genetic dissimilarity between obesity and type 2 diabetes. Together with colleagues from Dundee and Oxford universities in the UK and the Vanderbilt Genetics Institute in the US, the team recently published their findings in the journal Nature Metabolism.

https://www.ludc.lu.se/article/genetic-driven-approach-defining-two-obesity-profiles-convey-highly-concordant-and-discordant - 2026-08-21

Swedish research about different forms of type 2 diabetes is relevant for Indian people

Researchers at Lund University have previously shown that type 1 diabetes and type 2 diabetes can be divided into five subgroups, and that there are genetic differences between the four subgroups relating to type 2 diabetes. A research collaboration between Sweden and India now highlights similarities and differences between patient groups in India and Europe. The knowledge can be used to improve

https://www.ludc.lu.se/article/swedish-research-about-different-forms-type-2-diabetes-relevant-indian-people - 2026-08-21

Epigenetics and genetics help illustrate how diabetes care can be individualised

Precision medicine aims to deliver the right treatment to the right person at the right time. What does this mean for people with type 2 diabetes? Some of the research at Lund University Diabetes Centre (LUDC) focuses on the progression of type 2 diabetes to help develop more targeted treatments. Epigenetics can become a useful tool when diabetes care is tailored to the individual. People with typ

https://www.ludc.lu.se/article/epigenetics-and-genetics-help-illustrate-how-diabetes-care-can-be-individualised - 2026-08-21

New discoveries about where atherosclerotic plaques rupture can lead to preventive treatments

A common cause of myocardial infarction and stroke is the rupture of atherosclerotic plaques. The exact location of plaque ruptures has previously been unknown, but now researchers at Lund University have mapped this. The research team has also identified an enzyme, a marker, that they hope will help predict who is at risk of having a myocardial infarction or a stroke due to a ruptured atheroscler

https://www.ludc.lu.se/article/new-discoveries-about-where-atherosclerotic-plaques-rupture-can-lead-preventive-treatments - 2026-08-21

Type 2 diabetes researchers receive support from the Hjelt Diabetes Foundation

Every year, the Bo and Kerstin Hjelt Diabetes Foundation awards three diabetes researchers at Lund University Diabetes Centre (LUDC) each a project grant of 47,500 euro. One of the researchers awarded a grant this year studies atherosclerotic plaques in patients with type 2 diabetes. These patients are more likely to develop cardiovascular disease due to plaque rupture compared to people without t

https://www.ludc.lu.se/article/type-2-diabetes-researchers-receive-support-hjelt-diabetes-foundation - 2026-08-21

Gut and mouth bacteria give researchers new clues about atherosclerosis

What is the link between atherosclerosis and gut and mouth bacteria? Researchers behind a large new study have found several new connections. In the long term, this knowledge can benefit people with type 2 diabetes, a group with an increased risk of developing atherosclerosis. In atherosclerosis, fat and calcium have accumulated in the artery walls over time, forming so called atherosclerotic plaq

https://www.ludc.lu.se/article/gut-and-mouth-bacteria-give-researchers-new-clues-about-atherosclerosis - 2026-08-21

Positive metabolic effects of gastric bypass disappear quickly

A new study from Lund University in Sweden raises questions about the efficacy of bariatric operations involving gastric bypass. The results show that the biggest metabolic changes happened directly after surgery. Just a year after the operation, the concentration of metabolites and fats had returned to almost the same levels as before the procedure.  Previous research has shown that the majority

https://www.ludc.lu.se/article/positive-metabolic-effects-gastric-bypass-disappear-quickly - 2026-08-21

Patrik Lindskoug ny professor i civilrätt

Rektor har den 4 december fattat beslut om att anställa Patrik Lindskoug som professor i civilrätt vid Juridiska fakulteten. Patrik Lindskougs forskning är inriktad på nationell och internationell förmögenhetsrätt med särskilt fokus på sakrätt och insolvensrätt, främst i ett nordiskt perspektiv, men han är också generellt intresserad av internationell privaträtt och komparativ rätt. Patrik Lindsko

https://www.aclu.lu.se/artikel/patrik-lindskoug-ny-professor-i-civilratt - 2026-08-21

ACLU fyller 10 år!

År 2026 är det tio år sedan Affärsrättsligt centrum vid Lunds universitet (ACLU) bildades! Sedan starten 2016 har ACLU haft som ambition att samla och stärka de affärsjuridiska forskningsmiljöerna vid universitetet. En central utgångspunkt för ACLU:s verksamhet är att framgångsrik affärsjuridisk forskning förutsätter ett nära samspel mellan akademi och praktik. ACLU har därför arbetat aktivt för a

https://www.aclu.lu.se/artikel/aclu-fyller-10-ar - 2026-08-21

Centrumträff för amanuenser vid affärsjuridiska centrum i Sverige

Den 16–19 april samlades amanuenser från ACLU, GCCML och SCCL i Lund för en gemensam centrumträff med fokus på erfarenhetsutbyte, samordning och utveckling av gemensamma arbetssätt. I Sverige finns tre centrala centrum för samverkan och dialog mellan akademi och praktiserande affärsjurister: ACLU - Affärsrättsligt Centrum vid Lunds universitet,Gothenburg Center for Commercial and Maritime Law samt

https://www.aclu.lu.se/artikel/centrumtraff-amanuenser-vid-affarsjuridiska-centrum-i-sverige - 2026-08-21

Ny bok: Associationsrättens grunder

Niklas Arvidsson och Johan Adestam har skrivit en bok som behandlar grundläggande frågor inom associationsrätten Författare: Niklas Arvidsson & Johan Adestam Publikationsår: 2022 Bokförlag: Studentlitteratur Introduktion En betydande del av näringslivet och civilsamhället bedrivs av och i olika slags associationer. Associationsrätt handlar om de regler som möjliggör och styr verksamheten i associa

https://www.aclu.lu.se/artikel/ny-bok-associationsrattens-grunder - 2026-08-21

Major investment accelerates advanced therapies from research to patient

With SEK 36 million in funding, stakeholders in Skåne are joining forces to develop and commercialise breakthrough ATMP research – Advanced Therapy Medical Products. The aim is to accelerate the next generation of these therapies so that more potentially life-saving ATMP treatments reach patients who currently lack effective treatment options Through the ATMP Path2Patient project, stakeholders wil

https://www.innovation.lu.se/en/article/major-investment-accelerates-advanced-therapies-research-patient - 2026-08-21

Transforming Cancer Care: SAGA Diagnostics' Test Now Launched in the U.S.

SAGA Diagnostics, a portfolio company of LU Ventures, has the potential to transform cancer care by detecting cancer recurrence early with unparalleled sensitivity. Founded in 2016 from research in Lund, their groundbreaking test is now available in the U.S. From Lab to Life: The Research Behind SAGA's BreakthroughThere's a significant need for improved biomarkers to diagnose cancer, select the be

https://www.innovation.lu.se/en/article/transforming-cancer-care-saga-diagnostics-test-now-launched-us - 2026-08-21

Breakthrough for Xenergic: Energy-Saving Memory Enters Mass Production

LU Ventures portfolio company Xenergic, a spin-off from Lund University, has reached a pivotal commercial milestone. Its revolutionary low-power memory technology is now in mass production with a component manufacturer. In modern mobile phones, smartwatches, and other connected devices, the on-chip memory can be responsible for more than 50% of the total energy consumption. This massive power draw

https://www.innovation.lu.se/en/article/breakthrough-xenergic-energy-saving-memory-enters-mass-production - 2026-08-21